- Markets
- Chemicals
- BI
BI
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Bilcare Approves Subscription To Warrants Worth 960 Mln Rupees Issued By Unit Caprihans India
Dec 2 (Reuters) - Bilcare Ltd BIL.BO:
APPROVED SUBSCRIPTION TO WARRANTS WORTH 960 MILLION RUPEES ISSUED BY UNIT CAPRIHANS INDIA
Source text: ID:nBSE9Sjch6
Further company coverage: BIL.BO
(([email protected];;))
Dec 2 (Reuters) - Bilcare Ltd BIL.BO:
APPROVED SUBSCRIPTION TO WARRANTS WORTH 960 MILLION RUPEES ISSUED BY UNIT CAPRIHANS INDIA
Source text: ID:nBSE9Sjch6
Further company coverage: BIL.BO
(([email protected];;))
Bilcare June-Quarter Consol Net Loss 63.9 Million Rupees
Aug 14 (Reuters) - Bilcare Ltd BIL.BO:
BILCARE LTD JUNE-QUARTER CONSOL NET LOSS 63.9 MILLION RUPEES
BILCARE JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 1.94 BILLION RUPEES
Further company coverage: BIL.BO
(([email protected];))
Aug 14 (Reuters) - Bilcare Ltd BIL.BO:
BILCARE LTD JUNE-QUARTER CONSOL NET LOSS 63.9 MILLION RUPEES
BILCARE JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 1.94 BILLION RUPEES
Further company coverage: BIL.BO
(([email protected];))
Bilcare Says Names Deepa Mathur As CFO
Sept 6 (Reuters) - Bilcare Ltd BIL.BO:
NAMES DEEPA MATHUR AS CFO
Source text for Eikon: ID:nBSE9pkbDV
Further company coverage: BIL.BO
(([email protected];;))
Sept 6 (Reuters) - Bilcare Ltd BIL.BO:
NAMES DEEPA MATHUR AS CFO
Source text for Eikon: ID:nBSE9pkbDV
Further company coverage: BIL.BO
(([email protected];;))
Bilcare Says Nilesh Tiwari Resigns As CFO
Sept 1 (Reuters) - Bilcare Ltd BIL.BO:
NILESH TIWARI RESIGNS AS CFO
Source text for Eikon: ID:nBSEClYWs
Further company coverage: BIL.BO
(([email protected];))
Sept 1 (Reuters) - Bilcare Ltd BIL.BO:
NILESH TIWARI RESIGNS AS CFO
Source text for Eikon: ID:nBSEClYWs
Further company coverage: BIL.BO
(([email protected];))
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Bilcare do?
Bilcare Ltd specializes in manufacturing pharmaceutical packaging solutions with a focus on design, materials, regulatory compliance, and cost-efficiency. They also provide pharmaceutical research and clinical services.
Who are the competitors of Bilcare?
Bilcare major competitors are Rajshree Polypack, Emmbi Industries, RDB Rasayans, Sah Polymers, Worth Peripherals, B&A Packaging India, Kanpur Plastipack. Market Cap of Bilcare is ₹202 Crs. While the median market cap of its peers are ₹231 Crs.
Is Bilcare financially stable compared to its competitors?
Bilcare seems to be less financially stable compared to its competitors. Altman Z score of Bilcare is 0.95 and is ranked 8 out of its 8 competitors.
Does Bilcare pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Bilcare latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Bilcare allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Capital Work in Progress, Inventory, Short Term Loans & Advances
How strong is Bilcare balance sheet?
Bilcare balance sheet is weak and might have solvency issues
Is the profitablity of Bilcare improving?
No, profit is decreasing. The profit of Bilcare is -₹80.87 Crs for TTM, -₹33.24 Crs for Mar 2024 and ₹15.05 Crs for Mar 2023.
Is the debt of Bilcare increasing or decreasing?
Yes, The debt of Bilcare is increasing. Latest debt of Bilcare is ₹685 Crs as of Sep-24. This is greater than Mar-24 when it was ₹682 Crs.
Is Bilcare stock expensive?
Bilcare is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE. Latest PE of Bilcare is 0.0, while 3 year average PE is 6.82. Also latest EV/EBITDA of Bilcare is 30.61 while 3yr average is 18.97.
Has the share price of Bilcare grown faster than its competition?
Bilcare has given better returns compared to its competitors. Bilcare has grown at ~34.77% over the last 2yrs while peers have grown at a median rate of 15.24%
Is the promoter bullish about Bilcare?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Bilcare is 30.01% and last quarter promoter holding is 30.01%.
Are mutual funds buying/selling Bilcare?
There is Insufficient data to gauge this.